Global Surgical Glue Market - 2020-2027
発行: DataM Intelligence
Surgical glues (also called surgical sealants or adhesives) are used after a surgery or traumatic injury to bind together external or internal tissue. Surgical glues can be used in conjunction with or as an alternative to sutures and staples; they use a chemical bond to hold tissue together for healing or serve as a barrier to stop the flow of bodily fluids.
Advancements in the surgical glue market were primarily aimed at addressing the limitations of traditional wound sealing techniques. Furthermore, due to favorable biological and physical properties of surgical glue, more number of surgeons are using this technique to seal wounds. Surgical glue is derived from several natural biopolymers including gelatin, collagen, chitosan, albumin, and fibrin.
The market is driven is the rising number of traumatic injuries. The market growth is also majorly driven by the rise in the number of surgical procedures and burn cases, along with increasing incidences of road accidents, globally. The rising health awareness and high prevalence of the diseases (such as skin diseases, cancer, heart diseases, and respiratory diseases) have increased the opportunities for the surgeries.
According to the World Health Organization (WHO) 2020 report, estimates approximately 1.35 million people die each year as a result of road traffic crashes. 20 to 50 million people suffer from non-fatal injuries, with many incurring a disability as a result of their injury. 93% of the world's fatalities on the roads occur in low and middle-income countries, even though these countries have approximately 60% of the world's vehicles. Even within high-income countries, individuals from lower socioeconomic backgrounds are more likely to be involved in road traffic crashes. Thus, rising prevalence of diseases along with road injury cases is expected to drive the market.
Additionally, there are innumerable accessibility and availability of these devices across the globe, which is one the major reason that is pertaining towards the growth of surgical glue market. It has been observed that the citizens of both developed, as well as developing countries, are extensively spending on healthcare services due to the increasing disposable income of the residents of those countries and increasing issues regarding health.
According to a recent study published by Centers for Disease Control and Prevention (CDC) it has been established that the total expenditure on healthcare services in the U.S. has projected towards a total of $3.9 trillion. Moreover, according to a report furnished by the U.K. Office for National Statistics (ONS), U.K.'s total healthcare expenditure accounted for approximately $300 billion in the recent past.
Abovementioned data indicate that countries are increasingly spending on healthcare and related facilities owing to rising medical awareness, growth in disposable income, and various developments in surgical facilities. Thus, patients suffering from various diseases are going for surgeries (better and quick treatment options), which, in turn, is driving the global surgical glue market growth.
Surgical glue has several limitations associated with its usability and safety, such as allergic reactions, wound dehiscence, and skin infections. In addition, it is categorized as class II by the FDA and class B by the Drugs and Cosmetics Acts (1940) in India, which makes it a little risky and thus requiring clinical trials and further leading to legal complexities. The safety, quality, and performance of these materials are necessary facets requiring stringent evaluation for public health, which lead to complex and strict regulations for their affiliation. Therefore, these factors are hampering the growth of the surgical glue market.
The global dental implants market is segmented based on product by fibrin, collagen, gelatin, cyanoacrylate, polymeric hydrogel, and urethane-based adhesive. The cyanoacrylates segment held the largest market share. Cyanoacrylate is a sticky substance found in many glues. Cyanoacrylate poisoning occurs when someone swallows this substance or gets it on their skin. Once the applicator is initiated and the cyanoacrylate adhesive is applied to moist tissue the polymerization process occurs. A feature of our cyanoacrylate devices is that only a low level of heat is generated when this polymerization starts, consequently the patient does not experience the stinging or burning sensation that occurs with some competitor products.
Cyanoacrylate glue are biocompatible and do not need removal as they naturally slough off the skin as part of the natural wound healing process. The properties of cyanoacrylate, namely fast-setting, high tensile strength polymers that bind with the skins surface and are flexible, durable, waterproof and transparent on setting, make cyanoacrylate ideal for wound closure and skin barrier products. Cyanoacrylates provide a non-traumatic means of wound closure and can provide an enhanced patient experience over conventional wound closure methods. They are commonly used to close laparoscopic incisions and are much stronger than fibrin sealants and sutures. Cyanoacrylates are waterproof, flexible and require no dressing on the wound.
The Fibrin glue segment is expected to have positive market growth in the forecast period. Fibrin glue are a type of surgical adhesive derived from both human and animal (bovine) blood products. Ingredients in the fibrin sealant interact during application to form a clot made from the blood protein called fibrin. Fibrin sealants are effective for use in cardiovascular surgery, lung surgery and closure of the Dural (a fibrous membrane covering the brain and spinal cord) and can be used to close spleen and liver lacerations.
Fibrin sealant is additionally used in hemostasis processes in order to control bleeding during and after surgical procedure, which is one of the leading fibrin sealants market trends. Fibrin sealant comprises of fibrinogen and thrombin which plays a vital role in hemostasis process during severe bleeding. . Fibrin sealant is the only commercially available FDA-approved material for clinical use as a hemostat, sealant, and adhesive. Fibrin sealants are referred as most adopted hemostats worldwide.
Further, the market is also classified based on application as cardiovascular surgery, orthopedic surgery, general surgery, cosmetic surgery, pulmonary surgery, central nervous system surgery, other. The cardiovascular surgery segment is held the largest market share. Rise in incidence of diseases correspondingly drives the number of surgical procedures performed, thereby, boosting the usage of surgical glues in surgeries and mainly, cardiovascular procedures globally. It has been a standard procedure in most medical centers providing surgical services for several years. Both the range and the number of surgical procedures performed are constantly increasing, which is driving the segment.
The globally increasing aging population is one of the major drivers of this segment. According to WHO, the world's geriatric population is expected to nearly double from 12.0% to 22.0% between 2015 and 2050. The market is expected to be driven by a vascular malfunction in the geriatric population and a rise in congenital defects. Furthermore, physical inactivity and an unhealthy lifestyle are also increasing the incidence of cardiovascular conditions.
According to the American Heart Association Research, cardiovascular diseases accounted for more than 8 lakh deaths in the U.S. in 2016. It has been observed that these diseases claim more lives than chronic lower respiratory disease and cancer combined. Approximately 2,300 Americans die due to cardiovascular diseases each day, an average of one death every 38 seconds. This factor will drive the growth of the segment.
The cosmetic surgery segment is expected to have positive market growth in the forecast period. This is due to the increasing adoption of surgical glue for cosmetic procedures and burn treatment surgeries. It is further set to increase with the increasing number of facial cosmetic surgeries, increasing cases of skin injuries, growing incidence of burn injuries, and an increasing number of breast cancer patients undergoing mastectomy and breast reconstruction procedures across the globe. This factor will drive the growth of the market in the forecast period.
By region, the global dental implants market is segmented into North America, South America, Europe, Asia-Pacific, Middle-East, and Africa. Among all of the regions, North America dominated the global surgical glue market and is expected to grow at the highest CAGR during the forecast period. North America is anticipated to continue being the largest-growing surgical glue market in the coming years. The factors that have contributed to the growth include the increasing investments in R&D of medical adhesives and their several applications in different surgeries performed in the region. As per Heart Disease & Stroke Statistical Fact Sheet 2020, estimates that a minimum of 40,000 infants is expected to be affected each year by congenital heart defects in the United States. Of these, about 25% or 2.4 (per 1,000 live births), require treatment in the first year of life. Moreover, the increasing demand for and focus on cosmetic surgery, as well as its growing awareness of preventative and corrective treatment in the USA is driving the growth of the market in this region.
The Asia-Pacific region is expected to have third-largest share due to presence of a large patient pool, availability of skilled technicians at a comparatively lower price, and a defined regulatory framework favoring expedited product approvals. Furthermore, the booming medical tourism industry in countries such as India, China, and Malaysia are expected to boost demand for surgical glue.
The global surgical glue market is highly competitive with the presence of several international and local markets. Product diversification, revenue generation, and opportunities intensify the market competition B. Braun Melsungen AG, Baxter International Inc., Advanced Medical Solutions Group PLC, C. R. Bard Inc., Cardinal Health Inc., CryoLife Inc., Integra LifeSciences Holdings Corporation, Cohera Medical Inc., Takeda Pharmaceutical Company Limited., and Johnson & Johnson, Medtronic PLC. are the leading market players with significant market share. The major players are using product development, novel product launches, market expansion, and product diversification strategies for holding their position in the market.
The companies are entering into collaborations, mergers, strategic partnerships, and acquisitions to expand their presence and meet the rising demand for the surgical glue across the globe. For instance,
*The global surgical glue market report will provide access to approximately 61 market data tables, 46 figures, and 200 pages.